☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
breast cancer
Biotheryx Receives the US FDA’s IND Approval of BTX-9341 for Treating Breast Cancer
May 8, 2024
Novartis to Acquire Mariana Oncology, Expanding its Radioligand Therapy Pipeline
May 3, 2024
Daiichi Sankyo and AstraZeneca Report the P-III (DESTINY-Breast06) Study Data of Enhertu to Treat Breast Cancer
April 29, 2024
AstraZeneca’s Truqap Plus Faslodex Receives the CHMP’s Positive Opinion for Treating Breast Cancer
April 29, 2024
Roche’s Ventana HER2 (4B5) Test Receives CE Mark for HER2-Low Metastatic Breast Cancer
April 10, 2024
Merus Highlights the Preclinical Results from the Study of Zenocutuzumab for Cancer Treatment at the AACR 2024
April 9, 2024
Load more...
Back to Home